|
|
2006年畢業于中國醫科大學獲得法醫學學士學位，2009年畢業于南昌大學醫學院獲得細胞生物與分子生物學碩士學位，2012年畢業于上海交通大學醫學院獲得腫瘤學博士學位。2012年-2016年在上海市腫瘤研究所癌基因及相關基因國家重點實驗室工作。2016年8月至今任職于復旦大學附屬腫瘤醫院腫瘤研究所。近5年主持項目包括國家自然科學基金青年基金、面上項目各一項，教育部高校博士點基金項目一項，作為骨干參與科技部重點研發計劃一項并參與多項國家科技重大專項研究工作。近5年主要研究成果發表于Advanced Science, Cancer
Research, PLOS Biology, Theranostics, Cell Death & Differentiation, Scientific
Reports, Molecular Medicine, Chinese Journal of
Cancer等雜志。
研究領域：
1. 乳腺腫瘤干細胞自我更新與分化的調控機制研究；
2. 乳腺腫瘤干細胞與免疫微環境的相互作用與靶向治療研究；
3. 腫瘤干細胞參與化療抵抗的內源性與外源性調控與轉化研究。
代表性論著：
-
Zhang LX# , Qiang J# ,
Yang L# , Wang D, Adeel R, He X, Chen W, Sheng D, Zhou L, Jiang YZ,
Li T, Du Y, Feng J, Hu X, Zhang J, Hu XC, Shao ZM, Liu S*. IL1R2
blockade suppresses breast tumorigenesis and progression by impairing
USP15-dependent BMI1 stability. Advanced
Science, 2020;
7(1): 1901728.
-
Zhou L#,
Wang D#, Sheng D#, Xu J, Chen W, Qin Y, Du R, Yang X, He
X, Xie N*, Liu S*, Zhang LX*. NOTCH4 maintains quiescent mesenchymal-like breast
cancer stem cells via transcriptionally activating SLUG and GAS1 in
triple-negative breast cancer. Theranostics, 2020; 10(5):2405-2421.
-
Wang D#, Xu J#, Liu B,
He X, Zhou L, Hu X, Qiao F, Zhang A, Xu X, Zhang H, Wicha MS, Zhang LX, Shao ZM, Liu S*.
IL6 blockade potentiates the anti-tumor effects of γ–secretase
inhibitors in Notch3-expressing breast cancer. Cell Death &
Differentiation, 2018; 25(2):330-339.
-
Chen W#, Qin Y#, Wang D,
Zhou L, Liu Y, Chen S, Yin L, Xiao Y, Yao XH, Yang X, Ma W, Chen W, He X, Zhang LX, Yang Q, Bian X, Shao ZM, Liu
S*. CCL20 triggered by chemotherapy hinders the therapeutic efficacy
of breast cancer. PLoS Biology, 2018; 16(7):e2005869.
-
Zhang Y#, Zhang LX#, Liu XQ, Zhao FY, Ge C, Chen TY, Yao M, Li J*.
Id4 promotes cell proliferation in hepatocellular carcinoma. Chinese
Journal of Cancer, 2017; 36(1):19.
-
Zhang
LX, Ge C, Zhao FY, Zhang Y, Wang X, Yao M, Li J*. NRBP2
interactes with ANXA2 render hepatocellular carcinoma cell sensitive to
apoptosis through Akt signaling pathway. Cancer Research，2016; 76(23):7059-7071.
-
Zhang L#, Zhang LX#, Li H, Ge C, Zhao FY, Tian H, Chen T, Jiang G,
Xie H, Cui Y, Yao M, Li J*. CXCL3 contributes to CD133+ CSCs
maintenance and forms a positive feedback regulation loop with CD133 in HCC via
Erk1/2 phosphorylation. Scientific Report, 2016; 6:27426.
-
Zhang LX,
Sun HF, Zhao FY, Lu P, Ge C, Li H, Hou H, Yan M, Chen T, Jiang G, Xie H, Cui Y,
Huang X, Fan J, Yao M, Li J*. BMP4 administration induces
differentiation of CD133+ hepatic cancer stem cells, blocking their
contributions to hepatocellular carcinoma. Cancer Research, 2012; 72(16):4276-4285.
-
Lu P, Sun HF, Zhang LX, Hou H, Zhang L, Zhao F, Ge C, Yao M, Wang T, Li J*.
Isocorydine targets the drug-resistant cellular side population through
PDCD4-related apoptosis in hepatocellular carcinoma. Molecular Medicine,
2012; 18:1136-1146.
|
